Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEMANTINE vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEMANTINE vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN: Safety Overview

Metric MEMANTINE MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
Total FAERS Reports 5,892 175
Deaths Reported 608 0
Death Rate 10.3% N/A
Hospitalizations 2,474 45
Average Patient Age 73.3 yrs 35.7 yrs
% Female Patients 57.4% 51.6%
FDA Approval Date Apr 10, 2015 N/A
Manufacturer Seton Pharmaceuticals N/A
Route ORAL N/A
Marketing Status Prescription N/A